These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9677027)

  • 1. A longitudinal study of C3, C3d and factor Ba in burn patients in Hong Kong Chinese.
    Wan KC; Lewis WH; Leung PC; Chien P; Hung LK
    Burns; 1998 May; 24(3):241-4. PubMed ID: 9677027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
    Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
    J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the complement biomarker profile of C3 glomerulopathy.
    Zhang Y; Nester CM; Martin B; Skjoedt MO; Meyer NC; Shao D; Borsa N; Palarasah Y; Smith RJ
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1876-82. PubMed ID: 25341722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathways to complement activation during cardiopulmonary bypass.
    Collett B; Alhaq A; Abdullah NB; Korjtsas L; Ware RJ; Dodd NJ; Alimo E; Ponte J; Vergani D
    Br Med J (Clin Res Ed); 1984 Nov; 289(6454):1251-4. PubMed ID: 6437506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C3d levels in normal individuals of Chinese origin.
    Wan KC; Lewis WH
    Br J Biomed Sci; 1993 Mar; 50(1):8-12. PubMed ID: 8032298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of complement activation, C3 and interleukin-6 levels in burn patients and their role as prognostic markers.
    Modi S; Rashid M; Malik A; Shahid M
    Indian J Med Microbiol; 2014; 32(2):137-42. PubMed ID: 24713898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation in patients with amebic liver abscess.
    Muñoz LE; Salazar OG
    J Hepatol; 1987 Aug; 5(1):30-6. PubMed ID: 2888804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of C3 conversion by ELISA estimation of neo-determinants on the C3d moiety.
    Holmskov-Nielsen U; Jensenius JC; Teisner B; Erb K
    J Immunol Methods; 1986 Nov; 94(1-2):1-6. PubMed ID: 2431062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local and systemic activation of the whole complement cascade in human leukocytoclastic cutaneous vasculitis; C3d,g and terminal complement complex as sensitive markers.
    Dauchel H; Joly P; Delpech A; Thomine E; Sauger F; Le Loet X; Lauret P; Tron F; Fontaine M; Ripoche J
    Clin Exp Immunol; 1993 May; 92(2):274-83. PubMed ID: 8485913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.
    Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB
    Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation in patients with renal failure as detected through the quantitation of fragments of the complement proteins C3, C5, and factor B.
    Oppermann M; Haubitz M; Quentin E; Götze O
    Klin Wochenschr; 1988 Sep; 66(18):857-64. PubMed ID: 3184764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor B activation products in patients with systemic lupus erythematosus. A marker of severe disease activity.
    Kerr LD; Adelsberg BR; Schulman P; Spiera H
    Arthritis Rheum; 1989 Nov; 32(11):1406-13. PubMed ID: 2818657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free radical involvement in hypertrophic scar formation.
    Wan KC; Evans JH
    Free Radic Biol Med; 1999 Mar; 26(5-6):603-8. PubMed ID: 10218648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A complement C3 fragment equivalent to mammalian C3d from the common carp (Cyprinus carpio): generation in serum after activation of the alternative pathway and detection of its receptor on the lymphocyte surface.
    Nakao M; Miura C; Itoh S; Nakahara M; Okumura K; Mutsuro J; Yano T
    Fish Shellfish Immunol; 2004 Feb; 16(2):139-49. PubMed ID: 15123318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation before, during and after cardiopulmonary bypass.
    Bonser RS; Dave JR; John L; Gademsetty MK; Carter PG; Davies E; Taylor P; Gaya H; Lennox SC; Vergani D
    Eur J Cardiothorac Surg; 1990; 4(6):291-6. PubMed ID: 2361017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleavage of the complement system C3 component by HIV-1 proteinase.
    Kisselev AF; Mentele R; von der Helm K
    Biol Chem; 1997 May; 378(5):439-42. PubMed ID: 9191031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of hepatic necrosis and complement system activation in fulminant viral hepatitis].
    Hou J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):49-54. PubMed ID: 8324837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deposition of complement C3 and factor H in tissue traumatized by burn injury.
    Sriramarao P; DiScipio RG
    Immunopharmacology; 1999 May; 42(1-3):195-202. PubMed ID: 10408380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complement fragment C 3d in the plasma of patients with chronic polyarthritis].
    Stannat S; Peter HH; Raspe HH; Deicher H
    Z Rheumatol; 1986; 45(2):47-51. PubMed ID: 3487899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
    Mayes JT; Schreiber RD; Cooper NR
    J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.